Global Pharmaceutical CDMO Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

According to DIResearch＇s in-depth investigation and research, the global Pharmaceutical CDMO market size will reach 167,817 Million USD in 2025 and is projected to reach 274,274 Million USD by 2032, with a CAGR of 7.27% (2025-2032). Notably, the China Pharmaceutical CDMO market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

A Pharmaceutical Contract Development and Manufacturing Organization (CDMO) is a specialized service provider that offers comprehensive support to pharmaceutical and biotechnology companies in the development, manufacturing, and commercialization of drug products. CDMOs serve as strategic partners, providing expertise and infrastructure for various stages of the drug development process, including formulation development, analytical testing, clinical trial manufacturing, and commercial-scale production. These organizations play a crucial role in the pharmaceutical industry by offering flexible and cost-effective solutions, enabling companies to outsource specific aspects of their drug development and manufacturing processes. Pharmaceutical CDMOs contribute to accelerating time-to-market, reducing development costs, and ensuring compliance with regulatory standards, allowing pharmaceutical companies to focus on research, innovation, and core competencies.

The major global suppliers of Pharmaceutical CDMO include Lonza, Catalent, Patheon (Thermo Fisher Scientific), Aenova, Siegfried, Recipharm, Strides Shasun, Piramal, Metrics, AMRI, Famar, WuXi Biologics, Asymchem, Zhejiang Jiuzhou Pharmaceutical, Apeloa Pharmaceutical, Porton Pharma, Amatsigroup, Fujifilm Diosynth, Biotechnologies, PCI Pharma Services, Pfizer CentreOne, Samsung Biologics, AGC Biologics, Divi＇s Laboratories Ltd, Piramal Pharma Solutions, Syngene International Ltd, Aragen Life Sciences, Akums Drugs and Pharmaceuticals, IDT Australia, Mayne Pharma, BioCina, Southern RNA, PharmSky Research, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Pharmaceutical CDMO. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Pharmaceutical CDMO market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Pharmaceutical CDMO market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Pharmaceutical CDMO industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Suppliers of Pharmaceutical CDMO Include:

Lonza

Catalent

Patheon (Thermo Fisher Scientific)

Aenova

Siegfried

Recipharm

Strides Shasun

Piramal

Metrics

AMRI

Famar

WuXi Biologics

Asymchem

Zhejiang Jiuzhou Pharmaceutical

Apeloa Pharmaceutical

Porton Pharma

Amatsigroup

Fujifilm Diosynth

Biotechnologies

PCI Pharma Services

Pfizer CentreOne

Samsung Biologics

AGC Biologics

Divi＇s Laboratories Ltd

Piramal Pharma Solutions

Syngene International Ltd

Aragen Life Sciences

Akums Drugs and Pharmaceuticals

IDT Australia

Mayne Pharma

BioCina

Southern RNA

PharmSky Research

Pharmaceutical CDMO Product Segment Include:

Solid Formulation

Semi-solid Formulation

Liquid Formulation

Gas Formulation

Pharmaceutical CDMO Product Application Include:

Chemical Pharmaceutical

Biopharmaceutical

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global Pharmaceutical CDMO Industry PESTEL Analysis

Chapter 3: Global Pharmaceutical CDMO Industry Porter's Five Forces Analysis

Chapter 4: Global Pharmaceutical CDMO Major Regional Market Size (Revenue) and Forecast Analysis

Chapter 5: Global Pharmaceutical CDMO Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 6: Global Pharmaceutical CDMO Revenue and Forecast Analysis by Product Type

Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 8: Industrial Chain Analysis, Pharmaceutical CDMO Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis

Chapter 9: Research Findings and Conclusion

Chapter 10: Methodology and Data Sources

Table 1： Pharmaceutical CDMO Industry Development Status

Table 2： Pharmaceutical CDMO Industry Development Trends

Table 3： Global Pharmaceutical CDMO Revenue and Growth Rate (CAGR) by Country: 2024 VS 2025 VS 2032 (US$ Million)

Table 4： Global Pharmaceutical CDMO Revenue by Country (2020-2025) & (US$ Million)

Table 5： Global Pharmaceutical CDMO Revenue Market Share by Country (2020-2025)

Table 6： Global Pharmaceutical CDMO Revenue Forecast by Country (2026-2032) & (US$ Million)

Table 7： Global Pharmaceutical CDMO Revenue Market Share Forecast by Country (2026-2032)

Table 8： Global Pharmaceutical CDMO Market Revenue by Key Suppliers (2021-2025) & (US$ Million)

Table 9： Global Pharmaceutical CDMO Revenue Market Share by Key Suppliers (2021-2025)

Table 10： Global Key Suppliers Headquarter and Key Area Sales

Table 11： Market Mergers & Acquisitions, Expansion

Table 12： Global Pharmaceutical CDMO Market Size and Growth Rate (CAGR) Analysis by Type: 2024 VS 2025 VS 2032 (US$ Million)

Table 13： Global Pharmaceutical CDMO Revenue Analysis by Type (2020-2025) & (US$ Million)

Table 14： Global Pharmaceutical CDMO Revenue Forecast Analysis by Type (2026-2032) & (US$ Million)

Table 15： Lonza Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 16： Lonza Pharmaceutical CDMO Product Portfolio

Table 17： Lonza Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 18： Catalent Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 19： Catalent Pharmaceutical CDMO Product Portfolio

Table 20： Catalent Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 21： Patheon (Thermo Fisher Scientific) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 22： Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Product Portfolio

Table 23： Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 24： Aenova Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 25： Aenova Pharmaceutical CDMO Product Portfolio

Table 26： Aenova Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 27： Siegfried Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 28： Siegfried Pharmaceutical CDMO Product Portfolio

Table 29： Siegfried Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 30： Recipharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 31： Recipharm Pharmaceutical CDMO Product Portfolio

Table 32： Recipharm Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 33： Strides Shasun Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 34： Strides Shasun Pharmaceutical CDMO Product Portfolio

Table 35： Strides Shasun Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 36： Piramal Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 37： Piramal Pharmaceutical CDMO Product Portfolio

Table 38： Piramal Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 39： Metrics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 40： Metrics Pharmaceutical CDMO Product Portfolio

Table 41： Metrics Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 42： AMRI Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 43： AMRI Pharmaceutical CDMO Product Portfolio

Table 44： AMRI Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 45： Famar Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 46： Famar Pharmaceutical CDMO Product Portfolio

Table 47： Famar Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 48： WuXi Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 49： WuXi Biologics Pharmaceutical CDMO Product Portfolio

Table 50： WuXi Biologics Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 51： Asymchem Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 52： Asymchem Pharmaceutical CDMO Product Portfolio

Table 53： Asymchem Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 54： Zhejiang Jiuzhou Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 55： Zhejiang Jiuzhou Pharmaceutical Pharmaceutical CDMO Product Portfolio

Table 56： Zhejiang Jiuzhou Pharmaceutical Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 57： Apeloa Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 58： Apeloa Pharmaceutical Pharmaceutical CDMO Product Portfolio

Table 59： Apeloa Pharmaceutical Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 60： Porton Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 61： Porton Pharma Pharmaceutical CDMO Product Portfolio

Table 62： Porton Pharma Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 63： Amatsigroup Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 64： Amatsigroup Pharmaceutical CDMO Product Portfolio

Table 65： Amatsigroup Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 66： Fujifilm Diosynth Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 67： Fujifilm Diosynth Pharmaceutical CDMO Product Portfolio

Table 68： Fujifilm Diosynth Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 69： Biotechnologies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 70： Biotechnologies Pharmaceutical CDMO Product Portfolio

Table 71： Biotechnologies Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 72： PCI Pharma Services Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 73： PCI Pharma Services Pharmaceutical CDMO Product Portfolio

Table 74： PCI Pharma Services Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 75： Pfizer CentreOne Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 76： Pfizer CentreOne Pharmaceutical CDMO Product Portfolio

Table 77： Pfizer CentreOne Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 78： Samsung Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 79： Samsung Biologics Pharmaceutical CDMO Product Portfolio

Table 80： Samsung Biologics Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 81： AGC Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 82： AGC Biologics Pharmaceutical CDMO Product Portfolio

Table 83： AGC Biologics Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 84： Divi＇s Laboratories Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 85： Divi＇s Laboratories Ltd Pharmaceutical CDMO Product Portfolio

Table 86： Divi＇s Laboratories Ltd Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 87： Piramal Pharma Solutions Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 88： Piramal Pharma Solutions Pharmaceutical CDMO Product Portfolio

Table 89： Piramal Pharma Solutions Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 90： Syngene International Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 91： Syngene International Ltd Pharmaceutical CDMO Product Portfolio

Table 92： Syngene International Ltd Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 93： Aragen Life Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 94： Aragen Life Sciences Pharmaceutical CDMO Product Portfolio

Table 95： Aragen Life Sciences Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 96： Akums Drugs and Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 97： Akums Drugs and Pharmaceuticals Pharmaceutical CDMO Product Portfolio

Table 98： Akums Drugs and Pharmaceuticals Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 99： IDT Australia Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 100： IDT Australia Pharmaceutical CDMO Product Portfolio

Table 101： IDT Australia Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 102： Mayne Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 103： Mayne Pharma Pharmaceutical CDMO Product Portfolio

Table 104： Mayne Pharma Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 105： BioCina Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 106： BioCina Pharmaceutical CDMO Product Portfolio

Table 107： BioCina Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 108： Southern RNA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 109： Southern RNA Pharmaceutical CDMO Product Portfolio

Table 110： Southern RNA Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 111： PharmSky Research Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 112： PharmSky Research Pharmaceutical CDMO Product Portfolio

Table 113： PharmSky Research Pharmaceutical CDMO Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 114： Global Pharmaceutical CDMO Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032 & (US$ Million)

Table 115： Global Pharmaceutical CDMO Revenue Analysis by Application (2020-2025) & (US$ Million)

Table 116： Global Pharmaceutical CDMO Revenue Forecast Analysis by Application (2026-2032) & (US$ Million)

Table 117： Pharmaceutical CDMO Typical Customer List

Table 118： Pharmaceutical CDMO Distributors List

Figure 1： Pharmaceutical CDMO Product Pictures

Figure 2： Solid Formulation Picture Scope

Figure 3： Semi-solid Formulation Picture Scope

Figure 4： Liquid Formulation Picture Scope

Figure 5： Gas Formulation Picture Scope

Figure 6： Chemical Pharmaceutical Picture Scope

Figure 7： Biopharmaceutical Picture Scope

Figure 8： Others Picture Scope

Figure 9： Global Pharmaceutical CDMO Market Size Analysis：2024 VS 2025 VS 2032 (US$ Million)

Figure 10： Global Pharmaceutical CDMO Market Revenue and Growth Rate Analysis: (2020-2032) & (US$ Million)

Figure 11： Global Pharmaceutical CDMO Revenue Market Share by Country in 2024

Figure 12： United States Pharmaceutical CDMO Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 13： Germany Pharmaceutical CDMO Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 14： Japan Pharmaceutical CDMO Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 15： China Pharmaceutical CDMO Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 16： France Pharmaceutical CDMO Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 17： U.K. Pharmaceutical CDMO Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 18： South Korea Pharmaceutical CDMO Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 19： Canada Pharmaceutical CDMO Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 20： Italy Pharmaceutical CDMO Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 21： Russia Pharmaceutical CDMO Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 22： Mexico Pharmaceutical CDMO Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 23： Brazil Pharmaceutical CDMO Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 24： India Pharmaceutical CDMO Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 25： Vietnam Pharmaceutical CDMO Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 26： Thailand Pharmaceutical CDMO Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 27： South Africa Pharmaceutical CDMO Market Revenue and Growth Rate (2020-2032) & (US$ Million)

Figure 28： Global Pharmaceutical CDMO Revenue Market Share by Key Suppliers in 2024

Figure 29： Global Pharmaceutical CDMO Industry Competition Landscape

Figure 30： Global Pharmaceutical CDMO Market Size by Type 2020-2032 (US$ Million)

Figure 31： Global Pharmaceutical CDMO Market Share by Type: 2025 & 2032

Figure 32： Pharmaceutical CDMO Industry Chain Analysis

Figure 33： Global Pharmaceutical CDMO Revenue Market Share by Application (2020-2032)

Figure 34： Key Interview Objectives

Figure 35： Bottom-Up and Top-Down Research Methods